Neil Stahl
Overview
Neil Stahl received an average of $7.6M in compensation at Regeneron Pharmaceuticals from 2006 to 2015.
YearCompanyPositionCompensation
2015
Regeneron PharmaceuticalsExecutive Vice President, Research & Development$18M2014
Regeneron PharmaceuticalsExecutive Vice President, Research & Development$16M2013
Regeneron PharmaceuticalsExecutive Vice President, Research & Development$14M2012
Regeneron PharmaceuticalsExecutive Vice President, Research & Development$12M2011
Regeneron PharmaceuticalsSenior Vice President, Research & Development Sciences$3M2010
Regeneron PharmaceuticalsSenior Vice President, Research & Development Sciences$5M2009
Regeneron PharmaceuticalsSenior Vice President, Research & Development Sciences$3M2008
Regeneron PharmaceuticalsSenior Vice President, Research & Development Sciences$1M2007
Regeneron PharmaceuticalsSenior Vice President, Research & Development Sciences$2M2006
Regeneron PharmaceuticalsSenior Vice President, Research Development Sciences$1MSource: SEC filings on April 26, 2016, April 21, 2015, April 24, 2014, April 26, 2013, April 26, 2010, and April 24, 2009.
Related executives
We found eight more executives who work or worked at Regeneron Pharmaceuticals.
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
Marion McCourt
Regeneron Pharmaceuticals
Senior Vice President, Commercial
Robert Landry
Regeneron Pharmaceuticals
Chief Financial Officer
Daniel Van Plew
Regeneron Pharmaceuticals
Executive Vice President and General Manager, Industrial Operations and Product Supply
Robert Terifay
Regeneron Pharmaceuticals
Executive Vice President, Commercial
Murray Goldberg
Regeneron Pharmaceuticals
Chief Financial Officer
Randall Rupp
Regeneron Pharmaceuticals